| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2024 | 48 | 264,722 | IVW, IVE, SCHZ, IUSB | 13F-HR | 10/21/2024 | 000173081324000007 |
| Q2 2024 | 57 | 246,366 | IVW, IVE, SCHZ, IUSB | 13F-HR | 8/9/2024 | 000173081324000006 |
| Q1 2024 | 60 | 239,043 | IVW, IVE, SCHZ, IUSB | 13F-HR | 4/18/2024 | 000173081324000005 |
| Q4 2023 | 58 | 232,398 | IVW, IVE, SCHZ, IUSB | 13F-HR | 3/19/2024 | 000173081324000004 |
| Q3 2023 | 55 | 232,367 | IVW, IVE, SCHZ, IUSB | 13F-HR | 11/1/2023 | 000173081323000007 |
| Q2 2023 | 60 | 239,594 | IVW, IVE, SCHZ, IUSB | 13F-HR | 7/18/2023 | 000173081323000006 |
| Q1 2023 | 69 | 232,563 | IVE, IVW, SCHZ, IUSB | 13F-HR | 4/26/2023 | 000173081323000005 |
| Q4 2022 | 70 | 216,756 | IVE, IVW, SCHZ, IUSB | 13F-HR | 2/7/2023 | 000173081323000004 |
| Q3 2022 | 69 | 199,595 | IGIB, IVE, IEFA, IVW | 13F-HR | 10/28/2022 | 000173081322000005 |
| Q2 2022 | 51 | 213,484 | IGIB, IEFA, IVE, VMBS | 13F-HR | 7/22/2022 | 000173081322000004 |
| Q1 2022 | 54 | 241,221 | IGIB, IVE, IEFA, VMBS | 13F-HR | 4/20/2022 | 000173081322000002 |
| Q4 2021 | 54 | 253,964 | IGIB, IEFA, IVE, VMBS | 13F-HR | 1/31/2022 | 000173081322000001 |
| Q3 2021 | 54 | 239,048 | IGIB, IEFA, IVE, VMBS | 13F-HR | 10/29/2021 | 000173081321000001 |
| Q2 2021 | 56 | 232,195 | IGIB, IEFA, IVE, VMBS | 13F-HR | 8/9/2021 | 000108514621002275 |
| Q1 2021 | 52 | 214,807 | IGIB, IEFA, IVE, VMBS | 13F-HR | 5/12/2021 | 000108514621001586 |
| Q4 2020 | 50 | 193,170 | IGIB, IEFA, IVE, VMBS | 13F-HR | 2/9/2021 | 000108514621000523 |
| Q3 2020 | 48 | 190,959 | IGIB, IEFA, VMBS, IVE | 13F-HR | 10/29/2020 | 000108514620002685 |
| Q2 2020 | 23 | 169,151 | IGIB, IEFA, VMBS, IVE | 13F-HR | 7/9/2020 | 000108514620001727 |
| Q1 2020 | 23 | 145,915 | IGIB, IEFA, VMBS, IVE | 13F-HR | 5/27/2020 | 000108514620001648 |
| Q4 2019 | 45 | 164,813 | IGIB, IEFA, IVE, VMBS | 13F-HR | 1/27/2020 | 000108514620000298 |
| Q3 2019 | 46 | 157,907 | IGIB, IEFA, IVE, IVW | 13F-HR | 11/5/2019 | 000108514619002722 |
| Q2 2019 | 47 | 150,897 | IGIB, IEFA, IVE, IVW | 13F-HR | 7/29/2019 | 000173081319000028 |
| Q1 2019 | 47 | 145,317 | IGIB, IEFA, IVE, IVW | 13F-HR | 5/13/2019 | 000173081319000025 |
| Q4 2018 | 48 | 129,235 | IGIB, IEFA, IVE, IVW | 13F-HR | 2/5/2019 | 000173081319000023 |
| Q3 2018 | 46 | 136,433 | IGIB, IEFA, IVE, IVW | 13F-HR | 10/12/2018 | 000173081318000005 |
| Q2 2018 | 44 | 121,837 | IGIB, IEFA, SCHP, IVE | 13F-HR | 8/14/2018 | 000173081318000004 |
| Q1 2018 | 48 | 109,166 | IGIB, SCHP, IEFA, IVE | 13F-HR | 5/9/2018 | 000173081318000002 |
| Q4 2017 | 50 | 123,735 | IEFA, SCHP, IVE, IGIB | 13F-HR | 2/20/2018 | 000173081318000001 |